Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07231783

The Effect of Urolithin A (Mitopure®) Supplementation on Muscle Strength in Healthy Middle-Aged Adults

A Confirmatory, Randomised, Double-Blind, Placebo-Controlled, Parallel Study to Assess the Effects of a Dietary Supplement Containing Urolithin A (Mitopure®) on Muscle Strength and Performance in Healthy Middle-Aged Adults

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Amazentis SA · Industry
Sex
All
Age
40 Years – 65 Years
Healthy volunteers
Accepted

Summary

This is a randomised, double-blind, placebo-controlled, parallel study to assess the effects of Urolithin A (Mitopure®) supplementation on muscle strength and performance in healthy middle-aged adults. Participants will be randomized to consume Mitopure® (500 mg), Mitopure® (1000 mg), or placebo once daily for 6 months.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPlaceboPlacebo softgels
DIETARY_SUPPLEMENTMitopure® 500mgSoftgels providing 500 mg of Mitopure®
DIETARY_SUPPLEMENTMitopure® 1000mgSoftgels providing 1000 mg of Mitopure®

Timeline

Start date
2025-12-10
Primary completion
2027-10-31
Completion
2027-10-31
First posted
2025-11-17
Last updated
2026-03-31

Locations

1 site across 1 country: Ireland

Source: ClinicalTrials.gov record NCT07231783. Inclusion in this directory is not an endorsement.

The Effect of Urolithin A (Mitopure®) Supplementation on Muscle Strength in Healthy Middle-Aged Adults (NCT07231783) · Clinical Trials Directory